Considerations for initial therapy in the treatment of acute heart failure - Wikidata - awgldk - TriplyDB

Considerations for initial therapy in the treatment of acute heart failure

Considerations for initial therapy in the treatment of acute heart failure

http://www.wikidata.org/entity/Q26778120

about

Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure Broadcasting Not Properly: Using B-type Natriuretic Peptide Interval Likelihood Ratios and the Results of Other Emergency Department Tests to Diagnose Acute Heart Failure in Dyspneic Patients.

P2860

Q29994549-132575A9-98DD-4AFD-B0F3-046E3F6DC721 Q40935755-A5767268-585C-4A60-94F4-E10D8BB7FE18

P2860

Considerations for initial therapy in the treatment of acute heart failure

http://www.wikidata.org/entity/Q26778120

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Considerations for initial therapy in the treatment of acute heart failure

@ast

Considerations for initial therapy in the treatment of acute heart failure

@en

Considerations for initial therapy in the treatment of acute heart failure

@nl

type

label

Considerations for initial therapy in the treatment of acute heart failure

@ast

Considerations for initial therapy in the treatment of acute heart failure

@en

Considerations for initial therapy in the treatment of acute heart failure

@nl

prefLabel

Considerations for initial therapy in the treatment of acute heart failure

@ast

Considerations for initial therapy in the treatment of acute heart failure

@en

Considerations for initial therapy in the treatment of acute heart failure

@nl

P1433

Q26778120-8D0BA3F2-952A-40B9-9061-FCE48580170A

P1476

Q26778120-3C86D3A3-0D51-4BC5-BF50-31518E2BE3DC

P2093

Q26778120-31B7BA49-A4D1-465F-9170-F0279D47733D

Q26778120-9D80F895-0F15-4F48-9D0F-EE98E9D0D98D

Q26778120-9DD9DD80-9A65-4ADA-873D-D575288BCF12

Q26778120-DD497A56-C195-4EA0-B6DC-D034C95A80CE

P275

Q26778120-D2EED0D4-0B97-476F-988E-354F8F0B01B8

P2860

Q26778120-03E3FB8F-411D-4135-B62A-676B6CE566B2

Q26778120-09AE2F7A-EE26-436F-858F-9937FD4824C1

Q26778120-0A9061FF-D2E3-41D2-BB54-CE0C0D3B254D

Q26778120-0EF73A7E-014A-4D0D-B80C-A51A0118EAF9

Q26778120-18C0C35A-1B3B-40E4-BBB1-AF472F495BD2

Q26778120-1FEA40A7-F197-4820-BB5E-DC10690C3123

Q26778120-24DDF03E-64C5-46ED-ADC8-29BF8B3B346E

Q26778120-288AC255-98EC-4052-AF40-63474F271449

Q26778120-2BC3A953-7C7B-4F33-ABA7-311957D6F574

Q26778120-2D08FECF-30A8-497B-96C6-30B885ECF533

P2888

Q26778120-223571EB-889F-458C-80B0-90B78A41E447

P304

Q26778120-3325F681-9F56-44ED-BD94-4E537DD2F666

P31

Q26778120-338E7002-262E-48F1-AE7F-3B1C415D4E0E

Q26778120-FB630F77-FEB9-456A-831C-3B9EAB7F7BFB

P356

Q26778120-8942C0CC-21E6-4034-AD47-C71AC0D11D1A

P407

Q26778120-AFBA82A8-C5BD-4819-84FA-0443E6AD7B22

P433

Q26778120-C1503177-BB92-4254-BE67-0AC4F2679659

P478

Q26778120-1449CAC0-7AB7-478B-AD32-9B401C1DE5E2

P5008

Q26778120-38B1BA48-C7B3-445A-BE3B-021B38DD7A68

P577

Q26778120-F9DC9E58-6AD3-4424-BCB5-53E0BC46BC49

P5875

Q26778120-640D4960-7F09-4C71-9A31-DF246B6612E1

P6179

Q26778120-10152BE9-EEA9-47A7-8906-2270459292A6

P698

Q26778120-259D8D0F-05C5-4D19-8F4B-A8375420DC22

P921

Q26778120-73B03F1E-5956-4F90-92B1-CC47B4F3CC8F

P932

Q26778120-E6433EEE-7D61-4710-BB76-1CFFF09DF160

P356

S13054-015-1114-3

P1433

P1476

Considerations for initial therapy in the treatment of acute heart failure

@en

P2093

Adam J Singer

http://www.w3.org/2001/XMLSchema#string

Brian C Hiestand

http://www.w3.org/2001/XMLSchema#string

Chad M Cannon

http://www.w3.org/2001/XMLSchema#string

William F Peacock

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

Lung ultrasound: a new tool for the cardiologist.

Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

Barriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

P2888

s13054-015-1114-3

P304

399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13054-015-1114-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283711137

http://www.w3.org/2001/XMLSchema#string

P6179

1037717199

http://www.w3.org/2001/XMLSchema#string

P698

26556500

http://www.w3.org/2001/XMLSchema#string

P921

P932

4641403

http://www.w3.org/2001/XMLSchema#string